Physician profile
Rebecca Gibbon
NPI 1174004964
$4,808.57
in general payments reported to CMS, 2019-2025
6 companies · $3,406 in 2025
The $3,406 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.20 · 2023: $176 · 2024: $1,153 · 2025: $3,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,301 · Education: $1,750 · Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,301.36 |
| Education | $1,750.00 |
| Food and Beverage | $683.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,448.92 | 2022-2025 | |
| Boston Scientific Corporation | $149.52 | 2024 | Exalt Model D |
| Tela Bio, INC. | $139.21 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $34.59 | 2022-2024 | Progrip |
| Conmed Corporation | $20.96 | 2023 | Airseal |
| Becton, Dickinson and Company | $15.37 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Gibbon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.